Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil Iin Patients With Chronic Obstructive Pulmonary Disease

NCT00931385 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00931385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00931385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil Iin Patients With Chronic Obstructive Pulmonary Disease
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
Not reported
Enrollment
99 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive